Radiofrequency Ablation of Metastatic Pheochromocytoma

Aradhana M. Venkatesan, Julia Locklin, Edwin W. Lai, Karen T. Adams, Antonio Tito Fojo, Karel Pacak, Bradford J. Wood

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

In the present report on the preliminary safety and effectiveness of radiofrequency (RF) ablation for pheochromocytoma metastases, seven metastases were treated in six patients (mean size, 3.4 cm; range, 2.2-6 cm). α- and β-adrenergic and catecholamine synthesis inhibition and intraprocedural anesthesia monitoring were used. Safety was assessed by recording ablation-related complications. Complete ablation was defined as a lack of enhancement within the ablation zone on follow-up computed tomography. No serious adverse sequelae were observed. Complete ablation was achieved in six of seven metastases (mean follow-up, 12.3 months; range, 2.5-28 months). In conclusion, RF ablation may be safely performed for metastatic pheochromocytoma given careful attention to peri-procedural management.

Original languageEnglish (US)
Pages (from-to)1483-1490
Number of pages8
JournalJournal of Vascular and Interventional Radiology
Volume20
Issue number11
DOIs
StatePublished - Nov 2009
Externally publishedYes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Radiofrequency Ablation of Metastatic Pheochromocytoma'. Together they form a unique fingerprint.

Cite this